Xenios Platform

Xenios Platform
Full spectrum of extracorporeal lung and heart support

for Price / Quote
for Documentation
for Questions

XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering  lung and heart therapies on one single platform.

- the unique platform for three applications combining ICU (novalung: iLA activve system platform), cath lab (i-cor: i-cor system) and OR (medos: deltastream system)
- adapt the system to your needs
- increased safety through integrated emergency functions

Im Zukunftspark, 1
+49 7131 2706 422